Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Qualisteo, is a company based in Nice (France) specialized in energy efficiency for industrial and tertiary sites
ImCheck Therapeutics designs and develops immunotherapeutic antibodies for the treatment of cancer and autoimmune disease.
Axonics Modulation Technologies is a pre-revenue company developing novel implantable neuromodulation.
T-knife is a developer of T cell receptors intended for T cell therapy of cancer.
Cyllene Therapeutics is a French biotechnology business that is pioneering a novel approach termed pinpoint gene therapy.
Lhyfe is a producer and supplier of green hydrogen, generated through renewable energy sources.
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.
Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function.
Ariceum Therapeutics focuses on diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers.
MMI is focused on advancing robotic technology for soft tissue open surgery with the world's smallest wristed instruments.
Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.
Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).
Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.
ENYO Pharma is a biopharmaceutical company based in Lyon, France.
Qovoltis offers smart charging solutions for electric vehicles and a mobile app for remote management.
Skysun is a financial institution that provides financial solutions and services to the solar energy sector.
SciRhom is a biotech enterprise that translate advanced scientific findings into game-changing therapies for autoimmune diseases.
We are advancing novel antigen modulation technology that controls T cells to guide the immune system.
Alveus Therapeutics is a clinical-stage biotech company developing therapies for obesity and metabolic diseases.
Spiro Medical is a medical device company developing a groundbreaking Pulmonary Neuromodulation (PNM) System for asthma treatment.
Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.
Kestra Medical Technologies offers wearable medical devices which collects, store, and communicate patients vital performance data.
TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.
Andera Partners has invested in 63 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Andera Partners's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Medical Device. The firm invests across 28 different industry categories.
Among tracked funding rounds, Mineralys Therapeutics received $500.0M in a Post-IPO Debt round. Andera Partners's total known invested capital is $4.4B.
Andera Partners's average investment size is $98.4M across its portfolio of 63 companies.
Recent Andera Partners portfolio additions include Qualisteo, ImCheck Therapeutics, Axonics Modulation Technologies, T-knife, Cyllene Therapeutics. These companies were founded in 2020 or later.